All-optical binary counter

We experimentally demonstrate an all-optical binary counter composed of four semiconductor optical amplifier based all-optical switching gates. The time-of-flight optical circuit operates with bit-differential delays between the exclusive-OR gate used for modulo-2 binary addition and the AND gate used for binary carry detection. A movie of the counter operating in real time is presented

Efficient interrogation method of forward Brillouin scattering in optical fibers using a narrow bandwidth long-period grating

A new technique for the characterization of the effective refractive index modulation in optical fibers due to transverse acoustic mode resonances excited by electrostriction is reported. Resonances excited by an optical pulse are probed by a narrow bandwidth longperiod grating (LPG) inscribed in the fiber, which is interrogated by a CW beam. The LPG used in this experiment has a narrow bandwidth and high sensitivity to small mode index perturbations, allowing the measurement of index variations from below 10-9 to 10-6. Radial and torsional-radial acoustic modes were characterized up to 1.1 GHz. The linewidth of resonances was found to be much shorter than in previous reports in which long fiber lengths are typically required, obtaining Q factors as high as 5000

Antiphase dynamics of a chaotic multimode laser

Antiphase dynamics of an optically pumped NH3 bidirectional ring laser under the chaotic, phase-sensitive mode coupling is experimentally observed. Our experimental result suggests strongly that the dynamics is a generic behavior of the laser

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome